W D Bloomer Selected Research

W D Bloomer Research Topics

6	Hypoxia (Hypoxemia) 07/2010 - 01/2000
5	Neoplasms (Cancer) 01/2003 - 01/2001
1	Lung Diseases (Lung Disease) 07/2010
1	Neoplasm Micrometastasis 07/2010
1	Lymphoma (Lymphomas) 02/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2001
1	Breast Neoplasms (Breast Cancer) 02/2001
1	Hodgkin Disease (Hodgkin's Disease) 02/2001
1	Neoplasm Metastasis (Metastasis) 06/2000
1	Carcinoma (Carcinomatosis) 01/2000

6	Cytotoxins (Cytolysins)IBA 07/2010 - 01/2000
5	Tirapazamine (SR 4233)IBA 07/2010 - 01/2001
4	4- (3- (2- nitro- 1- imidazolyl)- propylamino)- 7- chloroquinoline hydrochlorideIBA 07/2010 - 01/2001
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2003 - 08/2001
2	Fluorouracil (Carac)FDA LinkGeneric 10/2002 - 08/2001
1	A-factor (Streptomyces)IBA 01/2003
1	9- (3- (2- nitro- 1- imidazolyl)- propylamino)cycopenteno(b)quinolineIBA 01/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2003
1	Immunoglobulin G (IgG)IBA 11/2001
1	Carcinoembryonic AntigenIBA 11/2001
1	Oxygen (Dioxygen)IBA 11/2001
1	4- (3- (2- nitro- 1- imidazolyl)- propylamino)- 7- trifluoromethylquinoline hydrochlorideIBA 09/2001
1	Melphalan (Alkeran)FDA LinkGeneric 08/2001
1	DNA (Deoxyribonucleic Acid)IBA 01/2001
1	Intercalating AgentsIBA 01/2001

2	Radiotherapy 07/2010 - 02/2001
2	Therapeutics 01/2003 - 11/2001
2	Drug Therapy (Chemotherapy) 10/2002 - 02/2001
1	Microelectrodes 11/2001
1	Electrodes (Electrode) 11/2001
1	Segmental Mastectomy (Lumpectomy) 02/2001
1	Adjuvant Chemotherapy 02/2001
1	Retreatment 06/2000
1	Brachytherapy 01/2000